secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0000950170-23-021218
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta Q1 net loss $30.8M, cash $332.1M, CFO resigning
------------------------------------------------------

- Net loss of $30.8M ($0.63 per share) for Q1 2023; R&D expenses $26.1M, G&A $8.2M.
- Cash and equivalents $332.1M as of March 31, 2023; runway expected into 2025.
- CFO Nadir Mahmood resigning effective June 30, 2023; successor search underway.
- NKX101 clinical update planned for Q2 2023; NKX019 update in H2 2023.
- Preclinical data on NK cell engineering presented at AACR 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023021218/0000950170-23-021218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023021218/nktx-20230511.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-021218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer